Therapeutic Solutions International, Announced They are Beginning a Phase 3 Clinical Trial for the Treatment of Severe Covid-19 using Umbilical Cord Mesenchymal Stem Cells. After having Amazing Results During the Phase 2 Trial Where 91% of Severely ill Covid-19 Patients Survived. – #Future

By
Mehabe
-
0
309

Source: https://therapeuticsolutionsint.com/therapeutic-solutions-international-announces-launching-of-phase-iii-clinical-trial-for-treating-covid-19-lung-damage-using-its-jadicell-universal-donor-stem-cell-drug/

RELATED ARTICLESMORE FROM AUTHOR

This site uses Akismet to reduce spam. Learn how your comment data is processed.